PGNRF yields 666.11% · PFE yields 6.13%● Live data
📍 PGNRF pulled ahead of the other in Year 1
Combined, PGNRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PGNRF + PFE for your $10,000?
Pan Global Resources Inc., a junior resource company, engages in the acquisition and exploration of mineral properties in Spain. It explores for lead, zinc, silver, gold, and copper deposits. The company has an option to acquire 100% interest in the Aguilas Project that includes 4 mineral exploration licenses covering 13,563 hectares, as well as additional mineral rights applications covering 2,803 hectares located in the provinces of Cordoba and Ciudad Real, Kingdom of Spain. It also has an option to acquire 100% interest in the Escacena Investigation Permit situated in Spain. The company was formerly known as Mosam Capital Corp. and changed its name to Pan Global Resources Inc. in December 2009. Pan Global Resources Inc. was incorporated in 2006 and is based in Vancouver, Canada.
Full PGNRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.